[LGND] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -67.74%
YoY- 1,112.89%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 10,608 15,958 14,737 13,005 9,580 11,651 13,635 -15.44%
PBT 1,241 2,150 2,008 2,025 3,804 1,370 950 19.55%
Tax -47 53 139 60 110 66 -1,636 -90.68%
NP 1,592 2,097 1,869 1,965 6,091 1,495 1,063 30.99%
Tax Rate 3.79% -2.47% -6.92% -2.96% -2.89% -4.82% 172.21% -
Total Cost 9,016 13,861 12,868 11,040 3,489 10,156 12,572 -19.92%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 15.01 13.14 12.68 15.11 63.58 12.83 7.80 54.89%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS 0.08 0.10 0.09 0.10 0.30 0.07 0.05 36.91%
EPS Diluted 0.07 0.10 0.09 0.09 0.30 0.07 0.05 25.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.